Anwar U, Arshad J, Naeem U, Zahid A, Jehan A, Ramzan S
Cureus. 2025; 16(12):e76457.
PMID: 39867074
PMC: 11769698.
DOI: 10.7759/cureus.76457.
Rastegar-Moghaddam S, Akbarian M, Rajabian A, Alipour F, Hojjati Shargh A, Masoomi R
Naunyn Schmiedebergs Arch Pharmacol. 2024; .
PMID: 39535596
DOI: 10.1007/s00210-024-03593-8.
Voicu S, Scarlatescu A, Apetroaei M, Nedea M, Blejan I, Udeanu D
Nutrients. 2024; 16(7).
PMID: 38613110
PMC: 11013872.
DOI: 10.3390/nu16071077.
Liu Z, Lv J, Xiang Y, Deng W, Huang H, Sun Y
Cureus. 2024; 16(3):e55682.
PMID: 38586713
PMC: 10997831.
DOI: 10.7759/cureus.55682.
Tsare E, Klapa M, Moschonas N
Hum Genomics. 2024; 18(1):15.
PMID: 38326862
PMC: 11465932.
DOI: 10.1186/s40246-023-00565-6.
Renal function changes in patients with subclinical hyperthyroidism: a novel postulated mechanism.
Allam M, El-Zawawy H, El-Zawawy T
Endocrine. 2023; 82(1):78-86.
PMID: 37490265
PMC: 10462537.
DOI: 10.1007/s12020-023-03361-3.
Minimal change disease with papillary thyroid carcinoma: a report of two adult cases.
Yin J, Li Z, Hao Z, Yu Z, Yu W, Yang G
BMC Nephrol. 2023; 24(1):202.
PMID: 37407942
PMC: 10324232.
DOI: 10.1186/s12882-023-03252-9.
Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder.
Lin M, Heizhati M, Gan L, Yao L, Yang W, Li M
Risk Manag Healthc Policy. 2022; 15:289-298.
PMID: 35221736
PMC: 8880707.
DOI: 10.2147/RMHP.S345059.
Biochemical changes in patients during hypothyroid phase after thyroidectomy.
Al-Janabi G, Hassan H, Al-Fahham A
J Med Life. 2022; 15(1):104-108.
PMID: 35186143
PMC: 8852639.
DOI: 10.25122/jml-2021-0297.
Thyroid hormones regulate both cardiovascular and renal mechanisms underlying hypertension.
Jankauskas S, Morelli M, Gambardella J, Lombardi A, Santulli G
J Clin Hypertens (Greenwich). 2020; 23(2):373-381.
PMID: 33377271
PMC: 8030083.
DOI: 10.1111/jch.14152.